Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds

Pd(II) and Pt(II) complexes with the anions of the model nucleobases 1-methylthymine (1-MethyH), 1-methyluracil (1-MeuraH), and 1-methylcytosine (1-MecytH) of the types [Pd(dmba)(mu-L)]2 [dmba = N,C-chelating 2-((dimethylamino)methyl)phenyl; L = 1-Methy, 1-Meura or 1-Mecyt] and [M(dmba)(L)(L')] [L = 1-Methy or 1-Meura; L' = PPh(3) (M = Pd or Pt), DMSO (M = Pt)] have been obtained. Palladium complexes of the types [Pd(C6F5)(N-N)(L)] [L = 1-Methy or 1-Meura; N-N = N,N,N',N'-tetramethylethylenediamine (tmeda), 2,2'-bipyridine (bpy), or 4,4'-dimethyl-2,2'-bipyridine (Me2bpy)] and [NBu4][Pd(C6F5)(1-Methy)2(H2O)] have also been prepared. The crystal structures of [Pd(dmba)(mu-1-Methy)]2, [Pd(dmba)(mu-1-Mecyt)]2.2CHCl3, [Pd(dmba)(1-Methy)(PPh3)].3CHCl3, [Pt(dmba)(1-Methy)(PPh3)], [Pd(tmeda)(C6F5)(1-Methy)], and [NBu4][Pd(C6F5)(1-Methy)2(H2O)].H2O have been established by X-ray diffraction. The DNA adduct formation of the new platinum complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the platinum complexes on plasmid DNA pBR322 were also obtained. Values of IC50 were also calculated for the new platinum complexes against the tumor cell line HL-60. All the new platinum complexes were more active than cisplatin (up to 20-fold in some cases).     

New palladium(II) and platinum(II) complexes with 9-aminoacridine: structures, luminiscence, theoretical calculations, and antitumor activity

The new complexes [Pd(dmba)( N10-9AA)(PPh 3)]ClO 4 ( 1), [Pt(dmba)( N9-9AA)(PPh 3)]ClO 4 ( 2), [Pd(dmba)( N10-9AA)Cl] ( 3), and [Pd(C 6F 5)( N10-9AA)(PPh 3)Cl] ( 4) (9-AA = 9-aminoacridine; dmba = N,C-chelating 2-(dimethylaminomethyl)phenyl) have been prepared. The crystal structures have been established by X-ray diffraction. In complex 2, an anagostic C-H...Pt interaction is observed. All complexes are luminescent in the solid state at room temperature, showing important differences between the palladium and platinum complexes. Complex 2 shows two structured emission bands at high and low energies in the solid state, and the lifetimes are in agreement with excited states of triplet parentage. Density functional theory and time-dependent density functional theory calculations for complex 2 have been done. Values of IC 50 were also calculated for the new complexes 1- 4 against the tumor cell line HL-60. All of the new complexes were more active than cisplatin (up to 30-fold in some cases). The DNA adduct formation of the new complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the complexes on plasmid DNA pB R322 were also obtained.     

New NIR-emitting complexes of platinum(II) and palladium(II) with fluorinated benzoporphyrins

New platinum(II) and palladium(II) complexes with fluorinated benzoporphyrins are prepared and characterized. The photo-physical and electrochemical properties, as well as quenching by oxygen are investigated. The complexes possess highly efficient room-temperature NIR phosphorescence and are excitable with blue- and red-light. The fluorinated derivatives show improved photo-physical properties and photo-stability. The new dyes are particularly suitable as indicators for the use in optical oxygen sensors.     

N-aminorhodamne complexes of palladium(II), palladium(IV) and platinum(II)

Summary TheN-aminorhodanine (L) complexes: PdLX, (X = Br or I), ML_1.5Cl₂ (M = Pd or Pt), PtL₂X₂ (X = Br, I or ClO₄), PdL₃(ClO₄)₂, PdL_1.5Cl₄ and PdL₃(ClO₄)₄ have been prepared and investigated. The ligand is bonded to the metal ion through the aminic nitrogen atom as monodentate or through this atom and the thiocarbonylic sulphur atom when it acts as chelating or bridging ligand. The carbonylic oxygen atom is never coordinated.     

New biimidazole and bibenzimidazole derivatives: mono and binuclear palladium(II) or platinum(II) complexes and heterobinuclear palladium(II)-rhodium(I) or platinum(II)-rhodium(I) complexes

Novel neutral biimidazolate or bibenzimidazolate palladium(II) and platinum(II) complexes of the type M(NN)₂(dpe) [M = Pd, Pt; (NN)₂^2? = BiIm^2?, BiBzIm^2?. dpe = 1,2-bis(diphenylphosphino) ethane] have been obtained by reacting MCl₂(dpe) with TI₂(NN)₂. Complexes M(NN)₂(dpe) which are Lewis bases react with HClO₄ or [M(dpe)(Me₂CO)₂](ClO₄)₂ to yield, respectively, mononuclear cationic complexes of general formula [M{H₂(NN)₂](dpe) (M = Pd, Pt; H₂(NN)₂ = H₂BiIm, H₂BiBzIm) and homobinuclear palladium(II) or platinum(II) cationic complexes of the type [M₂{μ - (NN)₂}(dpe)₂](ClO₄)₂. Reactions of M(BiBzIm)(dpe) with [Rh(COD) (Me₂CO)_X](ClO₄) render similar heterobinuclear palladium(II)-rhodium(I) and platinum(II)-rhodium(I) cationic complexes, of general formula [(dpe)M(μ-BiBzIm)Rh(COD)](ClO₄) (M = Pd, Pt; COD = 1,5-cyclooctadiene). Di- and mono-carbonyl derivatives [(dpe)M(μ-BiBzIm)Rh(CO)L](ClO₄) (M = Pd, Pt; L = CO, PPh₃) have also been prepared. The structures of the resulting complexes have been elucidated by conductance studies and IR spectroscopy.     

Some palladium(II) and platinum(II) lead bonded complexes

Complexes of the type M(PPh₃)₂(PbPh₃)₂ [M = Pd, (Ia) and Pt, (Ib)] have been prepared by oxidative addition of hexaphenyldilead to M(PPh₃)₄. The compound Pt(PPh₃)₂(PbPh₃)₂, (Ib), slowly decomposes in dichloromethane to give cis-Pt(PPh₃)₂(PbPh₃)Ph, (II). which can also be obtained by treating (Ib) with the stoichiometric amount of LiPh. Reaction of Pt(PPh₃)₄ with hexamethyldidead gives the complex Pt(PPh₃)₂(PbMe₃)Me directly.The MPb bonds are easily cleaved by bromine, iodine and hydrogen bromide. The X-ray structure of (II) has been determined using three-dimensional counter data and refined by the least-square method (R = 0.07). The crystals are monoclinic a = 22.501, b = 10.502, c = 24.120 Å, β = 113.43°, space group P2₁/c with Z = 4. The complex exhibits a cis configuration, with the coordination around the platinum atom essentially square-planar: the PtPb and PtC(phenyl)bond lengths are 2.698(1) and 2.055(3)Å, respectively.     

Quantitative structure activity relationships for some antitumor platinum(II) complexes

The INDO–SCF method is used to provide electronic indices which are used as independent variables. These attempt to account for the variation in the antitumor activity and toxicity observed within a series of analogs of cis-diamino dichloro platinum(II).     

Synthesis and characterization of palladium(II) and platinum(II) complexes with ferrocenylimidazole

The synthesis and characterization of ferrocenylimidazole complexes of platinum(II) and palladium(II) are described. Reaction of ferrocenylimidazoles with K₂MCl₄ (M = Pd, Pt) using a biphasic system of dichloromethane and ethanol/water provided the corresponding complexes 2a–2j in good yields. New synthetic routes for the synthesis of ferrocenylbenzylethers 2k–2o, bis(4-ferrocenylbenzyl)carbonate [2p] and 4-ferrocenylbenzylacetate [2q] are also described. These products were obtained by the reaction of 4-ferrocenylbenzyl-1H-imidazole-carboxylate and K₂PtCl₄ under various conditions. Compounds 2k–2o were also obtained by alternative routes which do not involve the use of a platinum salt. The crystal structures of 2b, 2q and plausible mechanisms for the formation of 2k, 2p and 2q are reported.     

Reactions of platinum(O) and palladium(O) complexes with mercury(II) compounds: New methods for the synthesis of organic platinum and palladium derivatives

Conclusions A new group of reactions between Pt^o and Pd^o complexes with organic and heteroorganic Hg^II compounds was found and studied. The reaction involves the insertion of L_nM^o into the bond between mercury and the heteroelement. The bimetallic compounds formed may be isolated or undergo immediate demercuration leading to divalent platinum and palladium -derivatives, depending on the nature of the substituents and ligands and reaction conditions.Article published by a decision of the editorial board of this journal, dated December 3. 1981.Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 9, pp. 2069–2089, September, 1982.     

Carbamoyl and alkoxycarbonyl complexes of palladium(II) and platinum(II)

Carbamoyl and alkoxycarbonyl complexes of palladium(II) and platinum(II) of the type M(pnp)(CONHR)Cl (pnp = 2,6-bis(diphenylphosphinomethyl)pyridine; M Pd, R  C₆H₅, p-CH₃C₆H₄, p-CH₃OC₆H₄, C₆H₁₁, t-Bu; M  Pt, R  C₆H₅), Pd(pnp)[CON(Pr)₂]Cl (Pr = propyl), M(pnp)(COOR)Cl (M  Pd, R  C₆H₅, CH₃; M  Pt, R  CH₃), Pd(pnp)(COOCH₃)₂ result from reaction of M(pnp)Cl₂ with carbon monoxide and amines or alkoxides at room temperature and atmospheric pressure.The carbamoyl complexes react with bases to give urethane or diphenylurea depending upon the experimental conditions.     

Heteroleptic platinum(II) and palladium(II) complexes with thiacrown and diimine ligands

We wish to report the synthesis, crystal structures, spectroscopic and electrochemical properties of several new Pt(II) heteroleptic complexes containing the thiacrown, 9S3 (1,4,7-trithiacyclononane) with a series of substituted phenanthroline ligands and related diimine systems. These five ligands are 5,6-dimethyl-1,10-phenanthroline(5,6-Me₂-phen), 4,7-dimethyl-1,10-phenanthroline(4,7-Me₂-phen), 4,7-diphenyl-1,10-phenanthroline(4,7-Ph₂-phen), 2,2′-bipyrimidine(bpm), and pyrazino[2,3-f]quinoxaline or 1,4,5,8-tetraazaphenanthrene(tap). All complexes have the general formula [Pt(9S3)(N₂)](PF₆)₂ (N₂ = diimine ligand) and form similar structures in which the Pt(II) center is surrounded by a cis arrangement of the two N donors from the diimine chelate and two sulfur atoms from the 9S3 ligand. The third 9S3 sulfur in each structure forms a longer interaction with the platinum resulting in an elongated square pyramidal structure, and this distance is sensitive to the identity of the diimine ligand. In addition, we report the synthesis, structural, electrochemical, and spectroscopic properties of related Pd(II) 9S3 complex with tap. The ¹⁹⁵Pt NMR chemical shifts for the six Pt(II) complexes show a value near −3290 ppm, consistent with a cis-PtS₂N₂ coordination sphere although more electron-withdrawing ligands such as tap show resonances shifted by almost 100 ppm downfield. The physicochemical properties of the complexes generally follow the electron-donating or withdrawing properties of the phenanthroline substituents.     

Reaction of platinum (II) and palladium (II) nitrite complexes with potassium bromide

The reaction of nitrite-bridged binuclear platinum and palladium complexes and KBr in aqueous solution is studied. It is shown that the Pt-O-N bridging bond dissociates during the reaction to yield two mononuclear complexes. Rate constants of the reaction at 15°C are determined.     

The chemistry of binuclear palladium(II) and platinum(II) complexes

The chemistry of binuclear palladium(II) and platinum(II) complexes has been reviewed. This review deals with complexes derived from various classes of ligands and covers various aspects, viz. synthesis, spectroscopic and structural features and chemical reactivity, of these complexes. Applications of these complexes are briefly described in the respected sections.     

Interaction of carboxyl functionalized catechols with palladium(II) and platinum(II) halide complexes

Summary A series of stable carboxyl substituted catecholato metal complexes of the type M(1,2-O₂C₆H₃R-4)(PPh₃)₂: M = Pd^II an Pt^II: R = CO₂H, CH₂CO₂H, C₂H₄CO₂H; have been prepared in high yield from reaction of the metal halide complex with catechols in the presence of a base. The compounds have been characterized on the basis of their elemental analyses. i.r. and n.m.r. spectra. The possibility of a metal carboxylato chelation had been considered and discussed on the light of the i.r. and n.m.r. spectra.     

Reactions of dimethyl acetylenedicarboxylate with hydridoalkynyl complexes of palladium(II) and platinum(II)

Reaction of trans-HM(PEt₃)₂ (CCC₆H₅) (M = Pt, Pd) with dimethyl acetylenedicarboxylate has given rans-{(CH₃O₂C)HC=C(CO₂CH₃)}M(PEt₃)₂ (CCC₆H₅). It is suggested that oligomerization of a terminal acetylene proceeds through an alkynylalkenyl derivative.     

New palladium(II) complexes with pyrazole ligands

The pyrazole ligand 3,5-dimethyl-4-iodopyrazole (HdmIPz) has been used to obtain a series of palladium(II) complexes (1–4) of the type [PdX₂(HdmIPz)₂] {X = Cl⁻ (1); Br⁻ (2); I⁻ (3); SCN⁻ (4)}. All compounds have been isolated, purified, and characterized by means of elemental analysis, IR spectroscopy, ¹H and ¹³C{¹H}-NMR experiments, differential thermal analysis (DTA), and thermogravimetry (TG). The TG/DTA curves showed that the compounds released ligands in the temperature range 137–605 °C, yielding metallic palladium as final residue. The complexes and the ligand together with cisplatin have been tested in vitro by MTT assay for their cytotoxicity against two murine cancer cell lines: mammary adenocarcinoma (LM3) and lung adenocarcinoma (LP07).     

Cytotoxicity,antioxidant and glutathione S-transferase inhibitory activity of palladium(II) chloride complexes bearing nucleobase ligands

Palladium(II) chloride complexes bearing the nucleobases, adenine, cytosine and guanine, have been synthesized and characterized by UV–vis spectrophotometric methods, magnetic susceptibility, molar conductivity, elemental analysis, FTIR and ¹H-NMR. The complexes were found to have the general composition PdCl₂(NH₃L) (where L = adenine, cytosine or guanine). Square-planar geometry is proposed for these Pd(II) complexes based on magnetic evidence and electronic spectra. The complexes as well as the free nucleobase ligands show varying degrees of cytotoxicity on human promyelocytic leukemia (HL60) and human histiocytic leukemia (U937) cell lines, with cis-[PdCl₂(NH₃)(Gua)] showing IC₅₀ values of 48.03 ± 9.67 and 11.12 ± 3.42 µM against HL60 and U937, respectively. The complexes as well as the ligands did not show anti-proliferative activity against a normal human cell line (NB1RGB). The complexes also show significant antioxidant activity against 2,2-diphenyl-1-picrylhydrazyl radical as well as glutathione S-transferase inhibitory activity.     

Coordination complexes of l-azetidine-2-carboxylic acid with platinum(II) and palladium(II)

Summary The complexes K[Pt(l-aze)Cl₂, [Pt(l-aze)₂] and [Pd(l-aze)₂] (l-aze = l-azetidine-2-carboxylate) were prepared. X-ray structures show that [Pt(l-aze)₂] and [Pd(l-aze)₂] are isomorphous, having a planar tetragonal geometry with a trans configuration around the Pt and Pd atoms. Slight puckerings of the MN(1)N(11)O(11) chelate ring (M = Pt or Pd) and the azetidine ring were observed. The circular dichroism (c.d.) spectra of the complexes in aqueous solution agree with the structures found in the solid state as far as the hexadecant rule is concerned, giving, for the trans configuration of [M(l-ia)₂] (where ia = imino acid), the profile of the c.d. signs for the three predominant d-d transitions as: +,-,-. I.r., conductivity and n.m.r. measurements are also reported and are in accord with the proposed structures.     

New palladium(II) complexes with pyrazole ligands

This study describes the synthesis, IR, ¹H, and ¹³C{¹H} NMR spectroscopic as well the thermal characterization of the new palladium(II) pyrazolyl complexes [PdCl₂(HmPz)₂] 1, [PdBr₂(HmPz)₂] 2, [PdI₂(HmPz)₂] 3, [Pd(SCN)₂(HmPz)₂] 4 {HmPz = 4-methylpyrazole}. The residues of the thermal decomposition were identified as Pd⁰ by X-ray powder diffraction. From the initial decomposition temperatures, the thermal stability of the complexes can be ordered in the sequence: 1 > 2 > 4 ≈ 3. The cytotoxic activities of the complexes and the ligand were investigated against two murine cancer cell lines: mammary adenocarcinoma (LM3) and lung adenocarcinoma (LP07) and compared to cisplatin under the same experimental conditions.